Colorectal Unit, Department of Surgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Discipline of Surgery, Faculty of Health and Medical Sciences, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
BJS Open. 2020 Aug;4(4):577-586. doi: 10.1002/bjs5.50301. Epub 2020 May 27.
Recovery of gastrointestinal function is often delayed after major abdominal surgery, leading to postoperative ileus (POI). Enhanced recovery protocols recommend laxatives to reduce the duration of POI, but evidence is unclear. This systematic review aimed to assess the safety and efficacy of laxative use after major abdominal surgery.
Ovid MEDLINE, Embase, Cochrane Library and PubMed databases were searched from inception to May 2019 to identify eligible RCTs focused on elective open or minimally invasive major abdominal surgery. The primary outcome was time taken to passage of stool. Secondary outcomes were time taken to tolerance of diet, time taken to flatus, length of hospital stay, postoperative complications and readmission to hospital.
Five RCTs with a total of 416 patients were included. Laxatives reduced the time to passage of stool (mean difference (MD) -0·83 (95 per cent c.i. -1·39 to -0·26) days; P = 0·004), but there was significant heterogeneity between studies for this outcome measure. There was no difference in time to passage of flatus (MD -0·17 (-0·59 to 0·25) days; P = 0·432), time to tolerance of diet (MD -0·01 (-0·12 to 0·10) days; P = 0·865) or length of hospital stay (MD 0·01(-1·36 to 1·38) days; P = 0·992). There were insufficient data available on postoperative complications for meta-analysis.
Routine postoperative laxative use after major abdominal surgery may result in earlier passage of stool but does not influence other postoperative recovery parameters. Better data are required for postoperative complications and validated outcome measures.
腹部大手术后,胃肠功能的恢复往往会延迟,导致术后肠麻痹(POI)。加速康复方案建议使用泻药来减少 POI 的持续时间,但证据并不明确。本系统评价旨在评估腹部大手术后使用泻药的安全性和疗效。
从建库至 2019 年 5 月,我们检索了 Ovid MEDLINE、Embase、Cochrane 图书馆和 PubMed 数据库,以确定专注于择期开放性或微创性腹部大手术的合格 RCT。主要结局是排便时间。次要结局是饮食耐受时间、肛门排气时间、住院时间、术后并发症和再次住院。
纳入了 5 项 RCT,共 416 例患者。泻药减少了排便时间(均数差(MD)-0.83(95%可信区间-1.39 至-0.26)天;P=0.004),但对于该结局指标,研究间存在显著的异质性。在肛门排气时间(MD-0.17(-0.59 至 0.25)天;P=0.432)、饮食耐受时间(MD-0.01(-0.12 至 0.10)天;P=0.865)或住院时间(MD 0.01(-1.36 至 1.38)天;P=0.992)方面无差异。关于术后并发症,没有足够的数据进行 meta 分析。
腹部大手术后常规使用术后泻药可能会更早地排便,但不会影响其他术后恢复参数。需要更好的数据来评估术后并发症和经过验证的结局指标。